Vamstarmarketing · Newsroom
Vamstar wins $1.2M Innovate UK Sovereign AI funding to show health technology developers what payers will accept before trial designs are locked
UK-built agentic AI platform links clinical evidence, health economics and market intelligence, so evidence and pricing gaps can be fixed while the trial can still change.October 2, 2026
The Secret Weapon Behind MedTech and Pharma’s Survival: Vamstar’s Agentic AI Is Quietly Reshaping Commercial Strategy Amid Economic Chaos
In the face of skyrocketing costs, tariff turmoil, and pricing pressure, leading life sciences companies are turning to a new kind of intelligence—one that doesn’t just inform decisions, but takes them.
May 22, 2025